ClinicalTrials.govpublic full text
Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNH
paroxysmal nocturnal hemoglobinuria, marchiafava-micheli syndrome, paroxysmal hemoglobinuria, paroxysmal cold hemoglobinuria, eculizumab, complement inactivating agents, hemolysis, anemia, hemolytic, anemia, hematologic diseases, bone marrow diseases, hemoglobinuria
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 834693
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.